Intellia Therapeutics
AUDIT: Intellia: The Biological API & the Sepsis Pivot
Audit of Intellia Therapeutics' in-vivo CRISPR trials. Examining the MAGNITUDE Phase 3 data, the 'Sepsis Pivot', and the severe clinical solvency risks.
Intellia Therapeutics